Danielle Antalffy

Stock Analyst at UBS

(1.49)
# 1486
Out of 5,329 analysts
221
Total ratings
45.35%
Success rate
5.24%
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
ATRC AtriCure
Maintains: Buy
60 58
29.96 93.59% 13 Apr 30, 2025
INMD InMode
Maintains: Neutral
19 17
15.02 8.19% 4 Apr 29, 2025
RXST RxSight
Downgrades: Neutral
45 16
15.17 5.47% 3 Apr 9, 2025
MDT Medtronic
Maintains: Neutral
85 95
84.53 12.39% 8 Feb 19, 2025
BSX Boston Scientific
Maintains: Strong Buy
105 130
105.38 23.36% 11 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
3.26 53.37% 2 Jan 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
146 148
133.06 11.23% 12 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
182
84.97 114.19% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
366 370
370 0% 6 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
90 75
76.73 -2.25% 12 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
112 107
102.83 4.06% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
7.56 -7.41% 5 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
163 95
78.73 20.67% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
35.48 111.39% 1 Jan 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
180
155.84 15.5% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
218
n/a n/a 4 Sep 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
405 322
159.13 102.35% 5 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
3
2.31 -2.6% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
43
30.68 40.16% 5 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
278
535.6 -48.1% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
45
20.04 124.55% 14 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 140
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 280
258 8.53% 12 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
975 825
11.49 7080.16% 2 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 20
n/a n/a 9 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 14
16.82 -16.77% 1 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 100
106.92 -6.47% 2 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
12.04 -0.33% 3 Mar 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 30
53.55 -43.98% 3 Mar 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 65
n/a n/a 6 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
38.78 16.04% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 85
n/a n/a 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 95
n/a n/a 6 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
270 275
168.64 63.07% 1 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
345 325
n/a n/a 12 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
36 80
n/a n/a 1 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
5.12 290.62% 3 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 66
n/a n/a 4 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
72 42
7.17 485.77% 7 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
3
0.74 305.41% 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
0.87 1624.14% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 75
n/a n/a 3 Oct 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 22, 2017